Upstream Bio (UPB) Enterprise Value: 2023-2025
Historic Enterprise Value for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $641.6 million.
- Upstream Bio's Enterprise Value fell 47.73% to $641.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$653.8 million, marking a year-over-year decrease of 162.93%. This contributed to the annual value of $410.7 million for FY2024, which is 473.99% up from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Enterprise Value is $641.6 million, which was up 225.57% from $197.1 million recorded in Q2 2025.
- Upstream Bio's 5-year Enterprise Value high stood at $1.2 billion for Q3 2024, and its period low was -$109.8 million during Q4 2023.
- For the 3-year period, Upstream Bio's Enterprise Value averaged around $237.5 million, with its median value being -$31.5 million (2024).
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 2,694.19% in 2024, then plummeted by 227.19% in 2025.
- Over the past 3 years, Upstream Bio's Enterprise Value (Quarterly) stood at -$109.8 million in 2023, then spiked by 473.99% to $410.7 million in 2024, then slumped by 47.73% to $641.6 million in 2025.
- Its Enterprise Value was $641.6 million in Q3 2025, compared to $197.1 million in Q2 2025 and -$103.1 million in Q1 2025.